Analyst downgrades typically lead to a negative perception of the company's stock in the short term, as they suggest a less favorable outlook on the company's future performance. The substantial decrease in the price target from $9 to $2.25 by a major financial institution like UBS is likely to be taken seriously by investors, potentially leading to a decrease in stock price.